Outline the latest pulmonary arterial hypertension (PAH) guidelines regarding early diagnosis and initiation of therapy, while taking into consideration how racial and ethnic disparities may play into treatment delays and patient outcomes
|
|
|
|
|
|
Describe a guideline-directed, evidence-based management plan for PAH that includes consideration of current guidelines, combination therapies, escalation strategies, current clinical trial data, and patient clinical characteristics
|
|
|
|
|
|
Discuss how to incorporate patient-focused management tactics in addressing racial and ethnic disparities as well as the practical considerations of patients with PAH
|
|
|
|
|
|